Browsing by Subject "Medicine, Research & Experimental"

ALERT: This system is being upgraded on Tuesday December 12. It will not be available for use for several hours that day while the upgrade is in progress. Deposits to DukeSpace will be disabled on Monday December 11, so no new items are to be added to the repository while the upgrade is in progress. Everything should be back to normal by the end of day, December 12.

Now showing items 1-12 of 12

A new look at an old disease: Is Pompe disease a neuromuscular disorder with CNS involvement?

Korlimarla, Aditi; Chen, Steven; Austin, Stephanie L; Provenzale, James M; Kishnani, Priya S (Molecular Genetics and Metabolism, 2020-02)
Cord blood derived cell therapy product, DUOC-01, accelerates remyelination in a murine model of cuprizone induced demyelination

Saha, Arjun; Buntz, Susan; Patel, Sachit; Bentz, Marcia; Snyder, David; Ozamiz, April; Rusche, Benjamin; ... (11 authors) (Cytotherapy, 2015-06)
DUOC-01, A CANDIDATE CELL THERAPY PRODUCT DERIVED FROM BANKED CORD BLOOD, ACCELERATES BRAIN REMYELINATION IN NSG MICE FOLLOWING CUPRIZONE FEEDING

Saha, A; Buntz, S; Patel, S; Matsushima, GK; Wollish, A; Kurtzberg, J; Balber, A (CYTOTHERAPY, 2014-04-01)
Effect of Lifestyle Changes after Percutaneous Coronary Intervention on Revascularization.

Wang, Yang; Xian, Ying; Chen, Tao; Zhao, Yanyan; Yang, Jinggang; Xu, Bo; Li, Wei (BioMed research international, 2020-01)

Objective:Whether optimal cardiovascular health metrics may reduce the risk of cardiovascular events in secondary prevention is uncertain. The study was conducted to evaluate the influence of lifestyle changes on clinical ...
Human cord blood derived CD14 cell therapy provides neuroprotection in aquired brain injury

Patel, Sachit; Saha, Arjun; Buntz, Susan; Bentz, Marcia; Scotland, Paula; Storms, Robert; Ramamurthy, Poorna; ... (9 authors) (Cytotherapy, 2015-06)
Neural engraftment of a cord blood-derived cell product following intrathecal transplantation

Storms, Robert; Lew, Joanna; Liu, Congxiao; Gentry, Tracy; Ozamiz, April; Rusche, Benjamin; Balber, Andrew; ... (8 authors) (Cytotherapy, 2015-06)
Neuronal and glial cell composition in a mouse brain slice culture model is useful in developing human cord blood derived cellular therapies for neonatal hypoxic-ischemic brain injury

Patel, S; Saha, A; Buntz, S; Kurtzberg, J; Balber, A (Cytotherapy, 2014-04)
Preclinical characterization of DUOC-01, a candidate cell therapy product derived from human banked umbilical cord blood intended for use in treatment of demyelinating diseases

Kurtzberg, J; Buntz, S; Gentry, T; Storms, R; Wenger, DA; Noldner, P; Zhou, J; ... (10 authors) (Cytotherapy, 2014-04)
PROTECTION OF BRAIN CELLS IN ORGANOTYPIC SLICE CULTURES EXPOSED TO OXYGEN AND GLUCOSE DEPRIVATION IS SPECIFICALLY MEDIATED BY CORD BLOOD CD14+CELLS

Saha, A; Buntz, S; Kurtzberg, J; Balber, A (CYTOTHERAPY, 2014-04-01)
Quantitative evaluation of white matter hyperintensities in the central nervous system in infantile Pompe disease

Korlimarla, Aditi; Stefanescu, Ela; Austin, Stephanie; Chen, Steven; Provenzale, James M; Kishnani, Priya S (Molecular Genetics and Metabolism, 2019-02)
The use of hydroxyethyl starch (HES) as a substitute for dextran 40 in the thaw and washing of HPC, apheresis products

Zhu, Fenlu; Heidtke, Sarah M; Kurtzberg, Joanne; Hari, Parameswaran; Margolis, David A; Keever-Taylor, Carolyn (Cytotherapy, 2015-06)
Tissue distribution of a cord blood-derived cell product following intrathecal transplantation

Storms, R; Liu, C; Gentry, T; Zhou, J; Ozamiz, A; Rusche, B; Balber, A; ... (8 authors) (Cytotherapy, 2014-04)

Browsing by Subject "Medicine, Research & Experimental"

A new look at an old disease: Is Pompe disease a neuromuscular disorder with CNS involvement? ﻿

Cord blood derived cell therapy product, DUOC-01, accelerates remyelination in a murine model of cuprizone induced demyelination ﻿

DUOC-01, A CANDIDATE CELL THERAPY PRODUCT DERIVED FROM BANKED CORD BLOOD, ACCELERATES BRAIN REMYELINATION IN NSG MICE FOLLOWING CUPRIZONE FEEDING ﻿

Effect of Lifestyle Changes after Percutaneous Coronary Intervention on Revascularization. ﻿

Human cord blood derived CD14 cell therapy provides neuroprotection in aquired brain injury ﻿

Neural engraftment of a cord blood-derived cell product following intrathecal transplantation ﻿

Neuronal and glial cell composition in a mouse brain slice culture model is useful in developing human cord blood derived cellular therapies for neonatal hypoxic-ischemic brain injury ﻿

Preclinical characterization of DUOC-01, a candidate cell therapy product derived from human banked umbilical cord blood intended for use in treatment of demyelinating diseases ﻿

PROTECTION OF BRAIN CELLS IN ORGANOTYPIC SLICE CULTURES EXPOSED TO OXYGEN AND GLUCOSE DEPRIVATION IS SPECIFICALLY MEDIATED BY CORD BLOOD CD14+CELLS ﻿

Quantitative evaluation of white matter hyperintensities in the central nervous system in infantile Pompe disease ﻿

The use of hydroxyethyl starch (HES) as a substitute for dextran 40 in the thaw and washing of HPC, apheresis products ﻿

Tissue distribution of a cord blood-derived cell product following intrathecal transplantation ﻿

A new look at an old disease: Is Pompe disease a neuromuscular disorder with CNS involvement?

Cord blood derived cell therapy product, DUOC-01, accelerates remyelination in a murine model of cuprizone induced demyelination

DUOC-01, A CANDIDATE CELL THERAPY PRODUCT DERIVED FROM BANKED CORD BLOOD, ACCELERATES BRAIN REMYELINATION IN NSG MICE FOLLOWING CUPRIZONE FEEDING

Effect of Lifestyle Changes after Percutaneous Coronary Intervention on Revascularization.

Human cord blood derived CD14 cell therapy provides neuroprotection in aquired brain injury

Neural engraftment of a cord blood-derived cell product following intrathecal transplantation

Neuronal and glial cell composition in a mouse brain slice culture model is useful in developing human cord blood derived cellular therapies for neonatal hypoxic-ischemic brain injury

Preclinical characterization of DUOC-01, a candidate cell therapy product derived from human banked umbilical cord blood intended for use in treatment of demyelinating diseases

PROTECTION OF BRAIN CELLS IN ORGANOTYPIC SLICE CULTURES EXPOSED TO OXYGEN AND GLUCOSE DEPRIVATION IS SPECIFICALLY MEDIATED BY CORD BLOOD CD14+CELLS

Quantitative evaluation of white matter hyperintensities in the central nervous system in infantile Pompe disease

The use of hydroxyethyl starch (HES) as a substitute for dextran 40 in the thaw and washing of HPC, apheresis products

Tissue distribution of a cord blood-derived cell product following intrathecal transplantation